Primary Role
Executive in Residence @
1 Investment in 1 Company
San Francisco

Person Details


Norman Winarsky is Vice President of Ventures at SRI International. As such he is responsible for creating SRI's highest value venture and license opportunities. He is a founder of SRI's venture process, including venture and license incubation, seed funding, the Entrepreneur-In-Residence program, and Venture Capital engagement.

Winarsky was co-founder and board member of Siri, which was spun out from SRI in January 2008. Siri has now been incorporated into the Apple iPhone 4S. He is currently a board member of Desti, Tempo, and Kuato, all SRI spinoffs. He is also an advisory board member of IMRSV.

He chairs SRI's Commercialization Board and the nVention Board, a partnership with the venture capital community that develops early-stage investment opportunities.

Winarsky helped found approximately 30 ventures, published approximately 50 papers, and holds three patents with several pending. He has a particular focus on natural language, computer vision, and artificial intelligence. (See - http://nyti.ms/90nHFm)

He is a Visiting Scholar at Stanford, and is also Chairman of the University of Chicago Visiting Committee for the Physical Sciences Division. He was a member of the National Academy Committee on Forecasting Future Disruptive Technologies, a National Science Foundation Fellow, an invited member of the mathematics department of the Institute for Advanced Study in Princeton, New Jersey, and an Assistant Professor at SUNY at Albany.

In 2011, Winarsky received the University of Chicago Alumni Service Award. In 2000, He and his team received an Emmy Award for outstanding achievement in technological advancement. In addition, Winarsky has received RCA's highest honor, the Sarnoff Award.

Winarsky graduated with a B.A., M.S., and Ph.D. in Mathematics from the University of Chicago, and was awarded Summa Cum Laude and Phi Beta Kappa. In addition he was awarded the Paul J. Cohen award for the outstanding student in Mathematics.

Specialties:Development of ventures and licensing opportunities, from concept through market development, team building, seed funding, identification of investors, and launch.

Jobs (4)


Executive in Residence

May 9, 2016 - Current   (6 months)

Visiting Scholar

Oct 1, 2010 - Current   (about 6 years)

Advisor, SRI Ventures

Nov, 2001 - Current   (almost 15 years)
Apr 1, 2010

Board & Advisor Roles (8)


Investments (1)

DateInvested InRoundDetails
Dec, 2011$2.5M / Seed

Education (3)


Add Memberships

Add Images

Add Videos